QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NYSEARCA:FBT

First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News

$146.67
-1.95 (-1.31%)
(As of 09/21/2023 ET)
Compare
Today's Range
$146.45
$148.31
50-Day Range
$146.67
$157.89
52-Week Range
$128.51
$166.00
Volume
25,616 shs
Average Volume
32,075 shs
Market Capitalization
$1.33 billion
Assets Under Management
$1.29 billion
Dividend Yield
0.00%
Net Expense Ratio
0.55%
FBT stock logo

About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

FBT Price History

FBT ETF News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
NYSE Arca Gold BUGS Index
Best Biotech ETFs for Q3 2022
Best Biotech ETFs for Q2 2022
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Get Ready for a Biotech ETF Comeback
See More Headlines
Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust NYSE Arca Biotechnology Index Fund
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:FBT
Inception Date
6/19/2006
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Arca Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$1.29 billion
Average Daily Volume
$47,783.10
Discount/Premium
-0.24%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Miscellaneous

Beta
0.79
Creation Unit
50,000
Creation Fee
$500.00

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

First Trust NYSE Arca Biotechnology Index Fund Expenses

TypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.40%0.57%0.53%0.50%0.50%
Other Expenses0.15%0.40%0.52%0.64%0.57%
Total Expense0.55%0.72%0.69%0.74%0.69%
Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%
Net Expense0.55%0.61%0.59%0.57%0.57%

First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & Exposure

FBT Sector Exposure

FBT Industry Exposure














FBT ETF - Frequently Asked Questions

How have FBT shares performed in 2023?

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $154.13 at the beginning of 2023. Since then, FBT stock has decreased by 3.6% and is now trading at $148.62.
View the best growth stocks for 2023 here
.

What does FBT invest in?

First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.29 billion assets under management.

What stocks does First Trust NYSE Arca Biotechnology Index Fund hold?
What is the management fee for First Trust NYSE Arca Biotechnology Index Fund?

First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY).

What is First Trust NYSE Arca Biotechnology Index Fund's stock symbol?

First Trust NYSE Arca Biotechnology Index Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FBT."

Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders?

First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (4.90%), Raymond James Financial Services Advisors Inc. (2.59%), Royal Bank of Canada (2.50%), LPL Financial LLC (2.08%), Raymond James & Associates (1.40%) and Berger Financial Group Inc (1.21%).

How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund?

Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust NYSE Arca Biotechnology Index Fund's stock price today?

One share of FBT stock can currently be purchased for approximately $148.62.

How much money does First Trust NYSE Arca Biotechnology Index Fund make?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has a market capitalization of $1.35 billion.

This page (NYSEARCA:FBT) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -